When the Deal Itself Was Wrong: Therapy for Post-Close Legal and Financial Betrayal

POST-EXIT FOUNDERS • April 22, 2026

Important framing: This is not legal or financial advice. Every deal, every claim, every jurisdiction is specific. Consult qualified counsel for the legal and financial dimensions of your situation. What follows is the clinical frame — what your nervous system, your psyche, and your sense of self need in order to heal inside whatever legal reality you’re inside.

The Email at 6:14 p.m.

It is 6:14 p.m. on a Tuesday. She is in the kitchen, starting dinner, and her phone buzzes on the counter. She picks it up without thinking — the reflexive, automatic gesture of a person who has spent a decade being available to her phone at all hours — and she sees the subject line before she has consciously decided to look at it.

The subject line contains the word “indemnification.”

She knows what that word means. She has known what it means since the deal process began, since her M&A attorney explained the reps-and-warranties structure, since she signed the disclosure schedules and the representations and warranties and the indemnification provisions that she had read carefully and that her attorney had reviewed and that she had believed, in good faith, accurately described the state of the company she was selling. She knows what the word means. She has not expected to see it in a subject line from the acquirer’s general counsel eleven months after the close.

She opens the email. There is a PDF attached. She opens the PDF. It is fourteen pages. She reads the first paragraph. The kitchen goes quiet in a specific way — not the absence of sound, because the refrigerator is still running and there is traffic outside and the television is on in the other room — but a specific narrowing of her auditory field, a focusing of her attention so complete that the peripheral sounds drop away and there is only the screen and the words on the screen and the specific, cold clarity of understanding what she is reading.

The acquirer is asserting a reps-and-warranties indemnification claim for $3.2 million. The claim cites a data-room item — a regulatory disclosure that she had included in the disclosure schedules, that her attorney had reviewed, that had been in the data room for the entirety of the due diligence process. It was on page 87 of a 200-page schedule. It was in a footnote. She put it there because her attorney told her to put it there. She put it there because she believed in the disclosure process. She put it there because she was trying to do the right thing.

She reads the letter twice. She puts the phone face-down on the granite counter. She stands at the kitchen island, both hands flat on the surface, looking at nothing in particular. The refrigerator hums. The television murmurs from the other room. Her husband walks in from the hallway, sees her face, and stops.

“What happened?” he asks.

She cannot speak yet. Not because she is crying — she is not crying — but because the words that would answer his question are not yet organized into anything she can say. What happened is that the deal she thought she had signed is not the deal she signed. What happened is that the company she sold in good faith is now being used as a weapon against her. What happened is that eleven months of believing the exit was behind her has just been retroactively revised, and she is standing in her kitchen at 6:14 p.m. on a Tuesday trying to understand what that means.

In my work with post-exit founders, the discovery that the deal itself was wrong is one of the most devastating and least supported experiences in the founder journey. It is distinct from the other forms of post-exit discovery — the co-founder betrayal, the acquirer’s cultural erasure, the personal revelation — in its specific combination of legal, financial, and psychological crisis. The founder who receives an indemnification letter is not just experiencing a legal problem. She is experiencing a trauma response, a financial crisis, and a profound disruption of her sense of reality — all simultaneously, all requiring different kinds of support, and all arriving at once.

What Does It Mean When the Deal Itself Was Wrong?

Reminder: This is not legal or financial advice. Every deal, every claim, every jurisdiction is specific. Consult qualified counsel for the legal and financial dimensions of your situation. What follows is the clinical frame.

The forms of deal-itself betrayal are numerous and varied, but they share a common clinical character: they involve the retroactive revision of the founder’s understanding of her own exit. The founder who receives an indemnification claim eleven months after close does not just have a legal problem; she has to revise her understanding of the past eleven months — to reinterpret the celebration, the relief, the gradual recovery of the post-exit period through the lens of what she now knows. The deal she thought she had signed was not the deal she signed. The exit she thought she had completed was not the exit she completed. The closure she thought she had achieved was not closure.

Pauline Boss, PhD, professor emerita of family social science at the University of Minnesota and author of Ambiguous Loss and The Myth of Closure, has documented the specific psychological harm of retroactive grief — the experience of having a loss that was believed to be resolved reopened by new information. The deal-itself betrayal is a form of retroactive grief: the founder who believed the exit was behind her discovers that it is not behind her, that the loss is ongoing, that the closure she believed she had achieved was provisional. This reopening of the grief is, in Boss’s framework, one of the most psychologically disorienting experiences available to a human being — more disorienting, in some ways, than the original loss, because it undermines the very capacity for closure that the healing process depends on.

For a broader understanding of the post-exit discovery framework, see my full article on betrayed by your exit. This article focuses specifically on the deal-itself face of that discovery — the face that sits at the intersection of legal, financial, and psychological crisis.

The Neurobiology of Discovering the Deal You Signed Was Not the Deal

Jennifer Freyd, PhD, professor emerit of psychology at the University of Oregon and founder of the Center for Institutional Courage, has documented the specific neurobiological effects of betrayal by a trusted party: the discovery that someone or something you trusted has harmed you produces a specific pattern of nervous system activation that is distinct from the activation produced by other forms of threat. Betrayal trauma is characterized by a specific form of cognitive disruption — the mind’s difficulty integrating the new information with the existing understanding of the relationship or institution — that Freyd describes as a form of “not knowing what you know.” The founder who discovers that the deal was wrong is experiencing this specific cognitive disruption: she knows what the indemnification letter says, and she cannot yet integrate that knowledge with her understanding of the deal she thought she signed.

Bessel van der Kolk, MD, psychiatrist and author of The Body Keeps the Score, describes the specific physiological response to the discovery of betrayal: the body’s threat-response system reactivates at the moment of discovery, producing the same pattern of sympathetic nervous system activation — elevated heart rate, cortisol surge, narrowing of attention, disruption of executive function — that was produced by the original traumatic experience. The founder who is standing in her kitchen at 6:14 p.m. with both hands flat on the granite counter is not being dramatic. Her nervous system is in a genuine threat response. Her body is responding to the discovery of betrayal with the same physiological urgency it would bring to a physical threat.

Galen Buckwalter, PhD, research psychologist, and Brad Klontz, PsyD, financial psychologist at Creighton University, have documented the specific construct of financial trauma — the clinically recognized form of psychological trauma that results from significant financial loss, threat, or betrayal. Their research demonstrates that financial trauma produces the same neurobiological effects as other forms of trauma: intrusive memories of the financial event, hypervigilance about financial information, avoidance of financial documents and conversations, and the specific cognitive distortions — hindsight bias, self-blame, catastrophizing — that characterize trauma responses. The founder who cannot open her email without checking the sender’s name, who wakes at 3 a.m. reviewing the disclosure schedules in her mind, who has begun to avoid conversations about the deal — she is not being irrational. She is experiencing financial trauma. And financial trauma responds to the same clinical interventions as other forms of trauma.

Daniel Kahneman, PhD, Nobel laureate and author of Thinking, Fast and Slow, adds a specific cognitive dimension that is particularly relevant to the deal-itself betrayal: hindsight bias — the tendency to believe, after the fact, that an outcome was predictable and therefore preventable — is one of the most powerful and most harmful cognitive distortions that the founder in this situation will experience. She will review the disclosure schedules and believe she should have seen the indemnification claim coming. She will review the advisor engagement letter and believe she should have caught the conflict of interest. She will review the earn-out provisions and believe she should have understood that they were engineered to fail. Hindsight bias is not accurate self-assessment; it is a cognitive distortion produced by the trauma response. The clinical work includes helping the founder distinguish between genuine errors in judgment — which deserve honest examination — and the hindsight bias that makes every decision look like a mistake in retrospect.

How Deal-Itself Betrayal Shows Up: Elaine’s Story

Elaine is 45. She sold her medtech company eleven months ago. The deal was the culmination of eight years of building — eight years of clinical trials and FDA submissions and investor rounds and the specific, grinding work of building a company in a regulated industry where every decision has a compliance dimension. She had done everything right. She had hired the right M&A attorney. She had engaged a reputable investment bank. She had built a thorough data room. She had reviewed the disclosure schedules with her attorney and her CFO. She had signed the reps and warranties believing them to be accurate representations of the company she had built.

The indemnification claim arrives at 6:14 p.m. on a Tuesday. $3.2 million. The claim cites a regulatory disclosure that she had included in the disclosure schedules — a disclosure about a pending FDA inquiry that had been in the data room since week two of the due diligence process, that her attorney had reviewed, that the acquirer’s counsel had reviewed, that had been the subject of a due diligence call in which the acquirer’s regulatory team had asked questions and received answers. It was on page 87 of a 200-page schedule. It was in a footnote. She put it there because her attorney told her to put it there.

She reads the letter twice. She puts the phone face-down on the granite. Her husband walks in and sees her face and stops. She cannot speak yet. She is trying to understand what she is reading, and the understanding is not coming cleanly because the understanding requires her to revise her understanding of the past eleven months — to reinterpret the celebration, the relief, the gradual recovery, the beginning of the identity work — through the lens of what she now knows.

She calls her attorney at 6:47 p.m. Her attorney tells her not to panic. He tells her the claim has weaknesses. He tells her they will respond. She listens. She takes notes. She is, as she has always been, organized and precise and functional in a crisis. She does not cry until 11:30 p.m., when her husband is asleep and she is sitting at the kitchen table with the disclosure schedules open on her laptop, looking for the footnote on page 87, trying to understand how something she disclosed in good faith has become a $3.2 million liability.

She finds the footnote. It is exactly where she put it. It says exactly what she thought it said. She closes the laptop. She sits in the dark kitchen. She is not crying anymore. She is in a specific, cold state of clarity that she will later describe to me as “the moment I understood that the deal was designed to do this.” Not necessarily by malice — she is not certain of malice — but by the asymmetric structure of the legal instruments, which placed all of the risk of post-close discovery on her and none of it on the acquirer.

Elaine came to see me three weeks after the indemnification letter arrived. She is sitting across from me, and she is describing the footnote on page 87, and she is doing what she has always done in a crisis: she is being precise, organized, and functional. She is also, beneath the precision and the organization, in a genuine trauma response that she has not yet named as such. The first thing I say to her is: “You’re allowed to be in shock. What you’re describing is a shock.” She looks at me for a moment. Then she says: “I thought I was past being shocked.” I tell her that being past being shocked is not the same as being immune to it. She nods. We begin.

The Six Common Forms of Deal-Itself Betrayal

In my clinical work with post-exit founders and in my own experience as a founder who navigated a complex exit, I have identified six common forms of deal-itself betrayal. Each has its own specific character, and each requires a somewhat different combination of legal, financial, and psychological response.

Form 1: Indemnification Claim Weaponization. The acquirer uses the reps-and-warranties indemnification provisions — provisions that were designed to protect against genuine material misrepresentations — to assert claims against the founder for items that were disclosed in the data room, that were known to the acquirer at signing, or that are below the materiality threshold specified in the agreement. This is the most common form of deal-itself betrayal in the post-close period, and it is the form that Elaine experienced. The clinical character of this form is specific: the founder who disclosed in good faith is now being penalized for the disclosure, which produces a specific form of cognitive dissonance — the belief that doing the right thing made things worse — that is particularly difficult to process.

Form 2: Earn-Out Engineering. The earn-out provisions — the contingent consideration that was supposed to reward the founder for the company’s post-close performance — were structured in a way that made achievement of the earn-out targets mathematically improbable or operationally impossible. This may involve targets that were set above the company’s historical growth trajectory, operational changes by the acquirer that undermine the company’s ability to hit the targets, or accounting treatments that reclassify revenue in ways that reduce the earn-out calculation. For a full clinical treatment of earn-out engineering, see my article on earn-out purgatory.

Form 3: Advisor Conflict of Interest. The founder’s M&A advisor — the investment banker, the attorney, or both — had an undisclosed financial relationship with the acquirer that created a conflict of interest in the representation. This may involve a concurrent engagement with the acquirer on another transaction, a referral relationship, or a fee structure that incentivized the advisor to close the deal at terms that were not optimal for the founder. The advisor conflict is a specific form of betrayal trauma because it involves the betrayal of a professional fiduciary relationship — a relationship that the founder entered in good faith and that was supposed to be organized around her interests.

Form 4: Working-Capital Adjustment Manipulation. The working-capital adjustment — the mechanism by which the purchase price is adjusted to reflect the actual working capital of the business at close — is used by the acquirer to reduce the effective purchase price through aggressive accounting interpretations that were not disclosed during the negotiation. Working-capital disputes are one of the most common sources of post-close conflict in M&A transactions, and they are frequently used by sophisticated acquirers to claw back a portion of the purchase price from founders who did not have the financial sophistication to anticipate the dispute.

Form 5: Post-Close Tax or Regulatory Landmine. The founder discovers, months or years after the close, that the company’s tax position or regulatory status contained a material problem that was not disclosed in the data room — either because it was genuinely unknown at the time of signing or because it was known and not disclosed. The tax or regulatory landmine is particularly devastating because it often arrives in the form of a government notice — a letter from the IRS, a regulatory inquiry, a state tax assessment — that carries the authority of the state and that the founder cannot negotiate or litigate in the same way she can negotiate or litigate a private claim.

Form 6: Hidden-in-Plain-Sight Misrepresentation. The data room contained information that, if properly understood, would have materially changed the founder’s understanding of the deal — but the information was presented in a way that obscured its significance. This may involve financial projections that were technically accurate but that omitted material context, legal opinions that were qualified in ways that were not explained, or due diligence responses that answered the literal question asked without volunteering the information that the question was designed to elicit. The hidden-in-plain-sight misrepresentation is the most psychologically complex form of deal-itself betrayal, because it involves the question of whether the founder should have known — a question that activates the hindsight bias and the self-blame that are characteristic of the trauma response.

Both/And: You Can Pursue Legal Remedy AND Do the Psychological Work at the Same Time

Neha is 39. She discovered, nine months after the close of her company’s acquisition, that her M&A advisor had an undisclosed engagement with the acquirer on another transaction that was concurrent with her own. The engagement had been disclosed in a footnote of the engagement letter — a footnote that her attorney had reviewed and that had been characterized to her as a standard conflict waiver. It was not standard. The conflict was material. And the terms of her deal — the purchase price, the earn-out structure, the indemnification provisions — reflected, in her attorney’s subsequent assessment, the advisor’s divided loyalty.

She is in litigation. She has been in litigation for four months. She has a good litigation team. She has a strong case. She is also, simultaneously, in therapy twice a week. She came to see me two months after the litigation began, at the recommendation of her litigation counsel, who had the clinical sophistication to recognize that his client was in a trauma response that was affecting her capacity to participate effectively in the legal process.

The moment that I want to tell you about happened in our sixth session. She had come in from a deposition preparation meeting, and she was describing the deposition strategy in the same precise, organized, functional way that she described everything. She was good at this. She was, in her litigation counsel’s assessment, an excellent witness — clear, credible, unflappable. She was also, in my assessment, using the litigation as the primary container for everything she was feeling about the betrayal — the rage, the grief, the specific humiliation of having been taken advantage of by someone she had hired to protect her interests.

“The litigation is not the same thing as the healing,” I said.

She looked at me. “I know that,” she said.

“Do you?” I asked. “Because you’ve spent the last forty-five minutes describing the deposition strategy, and we haven’t talked about how you’re sleeping.”

She was quiet for a moment. “I’m not sleeping,” she said. “I wake up at 3 a.m. and I’m running the timeline in my head. The engagement letter. The conflict waiver. The board meeting where he recommended the deal terms. I’m running it over and over, looking for the moment where I should have seen it.”

“That’s the trauma,” I said. “The litigation is handling the legal dimension of what happened. The therapy is handling the psychological dimension. They’re not the same thing. And you need both, on different tracks, without letting them collapse into each other.”

This is the Both/And of the deal-itself betrayal: you can pursue legal remedy AND do the psychological work at the same time. The legal work and the psychological work are not in competition. They are not alternatives. They are parallel tracks, each addressing a different dimension of the same harm. The legal track addresses the financial and contractual dimensions — the indemnification claim, the earn-out dispute, the advisor conflict. The psychological track addresses the nervous system, the identity, the sense of reality that the discovery has disrupted. Both tracks are necessary. Neither track is sufficient on its own.

The specific clinical risk that I want to name is the collapse of the two tracks into one: the founder who uses the litigation as the primary container for her psychological processing — who channels all of her rage and grief and need for vindication into the legal case — is at risk of two specific harms. First, she may make legal decisions that are driven by psychological needs rather than strategic interests — pursuing claims that are legally weak but psychologically necessary, or refusing settlements that are legally sound because accepting them feels like giving up. Second, she may delay the psychological healing work until the litigation resolves, which may take years, and which will not automatically produce the healing she is seeking even when it does resolve. Winning the lawsuit does not heal the trauma. The healing requires its own work, on its own track, regardless of the legal outcome.

For a deeper understanding of the specific dynamics of narcissistic co-founders and the betrayal patterns that often underlie deal-itself betrayal, see my article on when your co-founder is a narcissist. For the legal silencing dimension of post-exit betrayal, see my article on NDAs and non-disparagement clauses.

The Systemic Lens: How Deal Structure Protects Acquirers and What Women Founders Specifically Miss

The legal infrastructure of M&A exits is not neutral. It is organized around the interests of the more sophisticated party — typically the acquirer — and it places the burden of post-close risk disproportionately on the founder. The reps-and-warranties structure, the indemnification provisions, the earn-out mechanisms, the working-capital adjustment process — all of these instruments were developed by and for sophisticated institutional buyers, and they are calibrated to protect the buyer’s interests in ways that are not always legible to founders who are navigating the exit process for the first time or even the second time.

The research on gender and M&A advising is consistent and troubling: women founders receive, on average, less sophisticated M&A advising than their male counterparts. This is not primarily a function of the quality of the advisors available to women; it is a function of the networks through which M&A advisors are accessed, the pattern-matching biases of investment banks that are organized around the deals they have done before, and the specific dynamic in which women founders are more likely to be advised by generalist attorneys and boutique banks rather than by the specialized M&A counsel that sophisticated exits require. The result is that women founders are more likely to sign deals with provisions they do not fully understand, more likely to be surprised by post-close claims, and less likely to have the legal infrastructure in place to respond effectively when the claims arrive.

The dismissive framing of post-close surprises as “founder bitterness” is a specific form of institutional gaslighting that compounds the harm. The founder who raises concerns about an indemnification claim that she believes is pretextual, or an earn-out structure that she believes was engineered to fail, is frequently characterized — by the acquirer, by the acquirer’s counsel, and sometimes by her own advisors — as a disgruntled seller who is having difficulty accepting the terms of a deal she freely signed. This framing is not accurate. It is a power move. It is designed to discourage the founder from pursuing legitimate legal remedies by making the pursuit of those remedies feel like evidence of her own unreasonableness.

Private equity playbooks are specifically designed to engineer post-close leverage. The PE firm that acquires a founder’s company is not a passive buyer; it is an active financial engineer that has acquired hundreds of companies and that has developed specific strategies for maximizing the financial return on each acquisition. Those strategies frequently include post-close mechanisms — working-capital adjustments, indemnification claims, earn-out structures — that are designed to reduce the effective purchase price paid to the founder. The founder who is navigating a post-close dispute with a PE acquirer is not in a dispute between equals. She is in a dispute between a person who has done this once and an institution that has done this hundreds of times.

Understanding this systemic reality is not about victimhood. It is about accurate diagnosis. The therapy for female founders that I offer is specifically designed to address these systemic realities — to provide support that is calibrated to the specific demands of the female founder journey, including the specific demands of navigating post-close legal and financial betrayal in a system that was not designed with her interests in mind. For a broader understanding of why driven women are specifically targeted by these dynamics, see my article on why driven women are targets.

How to Heal: Trauma-Informed Therapy for Deal-Itself Betrayal

The healing work for deal-itself betrayal requires a specific clinical approach that is organized around the dual-track framework: the legal track, handled by qualified counsel, and the psychological track, handled by a trauma-informed therapist. The two tracks must not collapse into each other. The therapist is not the legal advisor. The attorney is not the therapist. Each professional handles a different dimension of the same harm, and the founder’s recovery depends on both tracks operating effectively and independently.

The therapeutic approach I use with founders navigating deal-itself betrayal is organized around Judith Herman’s three-stage framework, applied to the specific demands of this form of trauma.

Stage 1: Safety — Nervous System Stabilization Before Legal Strategy Work
The first and most important clinical task is nervous system stabilization. The founder who is in an acute trauma response — who is waking at 3 a.m. reviewing the disclosure schedules, who cannot open her email without checking the sender, who is in the hypervigilant, hyperactivated state of the threat response — is not in a position to make clear legal and financial decisions. The nervous system stabilization work is not a luxury; it is a prerequisite for effective legal strategy. The founder who is in a genuine trauma response will make decisions that are driven by the threat response — decisions that are fast, reactive, and organized around the need to eliminate the threat immediately — rather than by the strategic thinking that the legal situation requires.

The specific nervous system regulation practices that I teach in this stage include the physiological sigh (a double inhale followed by a long exhale, which activates the parasympathetic nervous system), the 5-4-3-2-1 grounding technique (orienting to the present moment through sensory awareness), and the specific somatic practices that Peter Levine, PhD, has developed for working with the physiological residue of trauma. These practices are not meditation or mindfulness in the generic sense; they are specific clinical tools for regulating the autonomic nervous system in the acute phase of a trauma response.

Stage 2: Remembrance and Mourning — Processing the Financial Trauma
The second stage involves the processing of the financial trauma itself — the construction of a coherent narrative of what happened, the processing of the emotional and somatic activation that the discovery produced, and the integration of the experience into the broader narrative of the founder’s life. This stage is where the IFS work is most valuable: the protector parts that are still trying to “prove” to the acquirer that she was right, the exile parts that carry the shame of having been taken advantage of, the manager parts that are running the legal strategy in the therapy room when they should be running it with the attorney.

Brad Klontz, PsyD’s money scripts work is particularly valuable in this stage for addressing the specific cognitive distortions that financial trauma produces. Money scripts — the unconscious beliefs about money that were formed in childhood and that shape the adult’s relationship to financial events — are activated by financial trauma in ways that compound the harm. The founder who grew up with the money script “money is dangerous” may interpret the indemnification claim as confirmation of that belief. The founder who grew up with the money script “I must be financially perfect” may interpret the post-close dispute as evidence of her own inadequacy. Identifying and challenging these money scripts is a specific therapeutic task that is distinct from the legal and financial work of the dispute itself.

The EMDR work in this stage targets the specific memory fragments that carry the most activation: the moment of reading the indemnification letter, the board meeting where the advisor recommended the deal terms, the signing ceremony where she believed she was completing something. The EMDR processing allows the nervous system to metabolize the activation associated with these memories without requiring the founder to relive them in their full intensity.

Stage 3: Reconnection — Building a Life That Is Not Organized Around the Dispute
The final stage is the construction of a life that is not organized around the legal dispute — a life in which the indemnification claim or the earn-out dispute is a problem being handled by qualified counsel rather than the defining feature of the founder’s identity. This is the stage at which the trauma-informed executive coaching work becomes most relevant: the forward-looking work of building the next chapter from a place of genuine freedom rather than from the weight of the unresolved dispute.

The specific clinical risk in this stage is the collapse of identity into the lawsuit — the founder who defines herself primarily as the person who was wronged by the deal, who organizes her professional and personal life around the litigation, who cannot imagine who she is when the case is resolved. The therapeutic work in this stage involves helping the founder maintain a sense of self that is distinct from the dispute — a self that exists before and after and alongside the legal process, that has a life and a future that are not contingent on the legal outcome.

Elaine is still in the indemnification dispute. It will likely resolve in the next six months, one way or another. She is also, simultaneously, doing the psychological work — the nervous system stabilization, the IFS work, the EMDR processing of the specific memories that carry the most activation. She is on two tracks. The legal track is handling the legal dimension of what happened. The psychological track is handling the rest. She is, for the first time since the indemnification letter arrived, sleeping through the night.

Neha’s litigation resolved eight months ago. She won. The settlement was significant. And the settlement did not, by itself, produce the healing she needed. The healing came from the psychological work — the two-years of therapy, the IFS work, the specific moment in our sixth session when she understood that the litigation and the healing were not the same thing. She is building something new now. Something small and deliberate and genuinely hers. She is building it from a different interior than the one that built the company she sold. She is building it from the ground that the healing work cleared.

That ground is available to you too. It does not require the legal dispute to resolve first. It requires the willingness to do the psychological work on its own track, in its own time, with the support of a therapist who understands what you are carrying. The legal outcome matters. And the healing is not contingent on it.

Related Reading

• Freyd, Jennifer J. Betrayal Trauma: The Logic of Forgetting Childhood Abuse. Cambridge, MA: Harvard University Press, 1996.
• Herman, Judith. Trauma and Recovery: The Aftermath of Violence — From Domestic Abuse to Political Terror. New York: Basic Books, 2015.
• Boss, Pauline. Ambiguous Loss: Learning to Live with Unresolved Grief. Cambridge, MA: Harvard University Press, 2000.
• van der Kolk, Bessel. The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. New York: Viking, 2014.
• Klontz, Brad, and Ted Klontz. Mind Over Money: Overcoming the Money Disorders That Threaten Our Financial Health. New York: Broadway Books, 2009.
• Kahneman, Daniel. Thinking, Fast and Slow. New York: Farrar, Straus and Giroux, 2011.

References

Peer-Reviewed Research (Vancouver)

1. van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, et al. Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS One. 2024;19(1):e0295926. doi:10.1371/journal.pone.0295926. PMID: 38198456.
2. Gómez JM, Smith CP, Gobin RL, Tang SS, Freyd JJ. Collusion, torture, and inequality: Understanding the actions of the American Psychological Association as institutional betrayal. J Trauma Dissociation. 2016;17(5):527-544. PMID: 27427782.
3. Cloitre M, Stolbach BC, Herman JL, van der Kolk B, Pynoos R, Wang J, et al. A developmental approach to complex PTSD: childhood and adult cumulative trauma as predictors of symptom complexity. J Trauma Stress. 2009;22(5):399-408. doi:10.1002/jts.20444. PMID: 19795402.
4. Payne P, Levine PA, Crane-Godreau MA. Somatic experiencing: using interoception and proprioception as core elements of trauma therapy. Front Psychol. 2015;6:93. doi:10.3389/fpsyg.2015.00093. PMID: 25699005.

Books & Cultural Sources (Chicago Author-Date)

• Dickinson, Emily. The complete poems of Emily Dickinson. Little, Brown, 1960.

Medical Disclaimer

Medical Disclaimer